PolyPeptide Group AG (LON:0AAJ)
London · Delayed Price · Currency is GBP · Price in CHF 26.23
-0.03 (-0.10%)
Feb 12, 2026, 4:55 PM GMT
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 809.33 million as of February 12, 2026. Its market cap has increased by 2.89% in one year.
Market Cap
809.33M
Enterprise Value
840.19M
Revenue
316.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.23
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.04B to 809.33M, a decrease of -60.32%. That is a compound annual growth rate of -17.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 827.55M | 2.37% |
| Dec 30, 2025 | 808.39M | -2.05% |
| Dec 30, 2024 | 825.31M | 53.37% |
| Dec 29, 2023 | 538.12M | -28.11% |
| Dec 30, 2022 | 748.55M | -79.59% |
| Dec 30, 2021 | 3.67B | 79.84% |
| Apr 29, 2021 | 2.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 2.04B |
| Oxford Nanopore Technologies | 1.36B |
| Oxford Biomedica | 1.00B |
| PureTech Health | 305.01M |
| Avacta Group | 269.00M |
| Faron Pharmaceuticals Oy | 191.04M |
| Scancell Holdings | 133.61M |
| Bioventix | 90.13M |